These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 6106027)
1. Tardive dyskinesia and other movement disorders in children treated with psychotropic drugs. Gualtieri TC; Barnhill J; McGinsey J; Schell D J Am Acad Child Psychiatry; 1980; 19(3):491-510. PubMed ID: 6106027 [No Abstract] [Full Text] [Related]
2. Tardive dyskinesia and other drug-induced movement disorders among handicapped children and youth. Gualtieri CT; Hawk B Appl Res Ment Retard; 1980; 1(1-2):55-69. PubMed ID: 6121532 [No Abstract] [Full Text] [Related]
3. Neuroleptic discontinuation and tardive dyskinesia risk. Sherr JD; Medoff D; Thaker G Am J Psychiatry; 1999 Jul; 156(7):1125-6. PubMed ID: 10401483 [No Abstract] [Full Text] [Related]
4. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia. Casey DE Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453 [TBL] [Abstract][Full Text] [Related]
5. Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia. Dufresne RL; Wagner RL J Clin Psychiatry; 1988 Nov; 49(11):435-8. PubMed ID: 2903141 [TBL] [Abstract][Full Text] [Related]
6. Rabbit syndrome and tardive dyskinesia: two complications of chronic neuroleptic treatment. Schwartz M; Weller B; Erdreich M; Sharf B J Clin Psychiatry; 1995 May; 56(5):212. PubMed ID: 7737962 [No Abstract] [Full Text] [Related]
7. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Marsden CD; Jenner P Psychol Med; 1980 Feb; 10(1):55-72. PubMed ID: 6104342 [TBL] [Abstract][Full Text] [Related]
8. Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents. Gualtieri CT; Quade D; Hicks RE; Mayo JP; Schroeder SR Am J Psychiatry; 1984 Jan; 141(1):20-3. PubMed ID: 6140865 [TBL] [Abstract][Full Text] [Related]
9. Tardive dyskinesia in young mentally retarded individuals. Gualtieri CT; Schroeder SR; Hicks RE; Quade D Arch Gen Psychiatry; 1986 Apr; 43(4):335-40. PubMed ID: 2869741 [TBL] [Abstract][Full Text] [Related]
10. Tardive dyskinesia and the behavioral consequences of chronic neuroleptic treatment. Gualtieri CT; Guimond M Dev Med Child Neurol; 1981 Apr; 23(2):255-9. PubMed ID: 6111511 [No Abstract] [Full Text] [Related]
14. Movement disorders with neuroleptic drug treatment. Tarsy D Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742 [TBL] [Abstract][Full Text] [Related]
15. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations. J Clin Psychiatry; 1998; 59 Suppl 12():23-7. PubMed ID: 9766616 [TBL] [Abstract][Full Text] [Related]
16. Aripiprazole-induced movement disorder. Zacher JL; Hatchett AD Am J Psychiatry; 2006 Jan; 163(1):160-1. PubMed ID: 16390909 [No Abstract] [Full Text] [Related]
17. Medical complications of new antipsychotic drugs. Umbricht D; Kane JM Schizophr Bull; 1996; 22(3):475-83. PubMed ID: 8873298 [TBL] [Abstract][Full Text] [Related]
18. [Effects and complications of neuroleptics (110 hospitalizations in neurology)]. Destee A; Montagne B; Rousseaux M; Petit H; Warot P Lille Med; 1980; 25(6):291-5. PubMed ID: 6105602 [No Abstract] [Full Text] [Related]
19. Pathophysiology of antipsychotic drug-induced movement disorders. Casey DE J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109 [TBL] [Abstract][Full Text] [Related]
20. Respiratory dyskinesia and dysarthria from prolonged neuroleptic use: tardive dyskinesia? Faheem AD; Brightwell DR; Burton GC; Struss A Am J Psychiatry; 1982 Apr; 139(4):517-8. PubMed ID: 6121492 [No Abstract] [Full Text] [Related] [Next] [New Search]